Literature DB >> 21768248

Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals.

Renate T de Jongh1, Paul Lips, Natasja M van Schoor, Kelly J Rijs, Dorly J H Deeg, Hannie C Comijs, Mark H H Kramer, Jan P Vandenbroucke, Olaf M Dekkers.   

Abstract

OBJECTIVE: To what extent endogenous subclinical thyroid disorders contribute to impaired physical and cognitive function, depression, and mortality in older individuals remains a matter of debate.
DESIGN: A population-based, prospective cohort of the Longitudinal Aging Study Amsterdam.
METHODS: TSH and, if necessary, thyroxine and triiodothyronine levels were measured in individuals aged 65 years or older. Participants were classified according to clinical categories of thyroid function. Participants with overt thyroid disease or use of thyroid medication were excluded, leaving 1219 participants for analyses. Outcome measures were physical and cognitive function, depressive symptoms (cross-sectional), and mortality (longitudinal)
RESULTS: Sixty-four (5.3%) individuals had subclinical hypothyroidism and 34 (2.8%) individuals had subclinical hyperthyroidism. Compared with euthyroidism (n=1121), subclinical hypo-, and hyper-thyroidism were not significantly associated with impairment of physical or cognitive function, or depression. On the contrary, participants with subclinical hypothyroidism did less often report more than one activity limitation (odds ratio 0.44, 95% confidence interval (CI) 0.22-0.86). After a median follow-up of 10.7 years, 601 participants were deceased. Subclinical hypo- and hyper-thyroidism were not associated with increased overall mortality risk (hazard ratio 0.89, 95% CI 0.59-1.35 and 0.69, 95% CI 0.40-1.20 respectively).
CONCLUSIONS: This study does not support disadvantageous effects of subclinical thyroid disorders on physical or cognitive function, depression, or mortality in an older population.

Entities:  

Mesh:

Year:  2011        PMID: 21768248     DOI: 10.1530/EJE-11-0430

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  45 in total

1.  Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement.

Authors:  Marina Djurovic; Alberto M Pereira; Johannes W A Smit; Olga Vasovic; Svetozar Damjanovic; Zvezdana Jemuovic; Dragan Pavlovic; Dragana Miljic; Sandra Pekic; Marko Stojanovic; Milika Asanin; Gordana Krljanac; Milan Petakov
Journal:  Endocrine       Date:  2018-06-29       Impact factor: 3.633

Review 2.  Hypothyroidism and depression.

Authors:  Colin M Dayan; Vijay Panicker
Journal:  Eur Thyroid J       Date:  2013-08-27

Review 3.  Psychiatric and cognitive manifestations of hypothyroidism.

Authors:  Mary H Samuels
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

4.  Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.

Authors:  Celestino Pio Lombardi; Raffaella Bocale; Angelina Barini; Antonella Barini; Annamaria D'Amore; Mauro Boscherini; Rocco Bellantone
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

Review 5.  A review of the evidence for and against increased mortality in hypothyroidism.

Authors:  Marianne Thvilum; Frans Brandt; Thomas H Brix; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2012-03-06       Impact factor: 43.330

Review 6.  The debate on treating subclinical hypothyroidism.

Authors:  Eng Loon Tng
Journal:  Singapore Med J       Date:  2016-10       Impact factor: 1.858

7.  Depression-like behavior in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.

Authors:  Jin-Fang Ge; Yun-Yun Peng; Cong-Cong Qi; Fang-Han Chen; Jiang-Ning Zhou
Journal:  Endocrine       Date:  2013-06-21       Impact factor: 3.633

8.  Physical performance in newly diagnosed hypothyroidism: a pilot study.

Authors:  D Gallo; E Piantanida; G Veronesi; A Lai; L Sassi; V Lombardi; E Masiello; P Premoli; E Bianconi; C Cusini; S Rosetti; M L Tanda; A Toniolo; M Ferrario; L Bartalena
Journal:  J Endocrinol Invest       Date:  2017-04-22       Impact factor: 4.256

9.  Thyroid hormones are associated with longitudinal cognitive change in an urban adult population.

Authors:  May A Beydoun; Hind A Beydoun; Ola S Rostant; Greg A Dore; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2015-08-08       Impact factor: 4.673

10.  The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition.

Authors:  Mary H Samuels; Irina Kolobova; Anne Smeraglio; Dawn Peters; Jeri S Janowsky; Kathryn G Schuff
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.